These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15163266)
1. Dosing differences between valproic acid concentrate and divalproex sodium: a case report. Coffey G; Botts S; de Leon J J Clin Psychiatry; 2004 May; 65(5):724-5. PubMed ID: 15163266 [No Abstract] [Full Text] [Related]
2. A pharmacokinetic and clinical evaluation of switching patients with bipolar I disorder from delayed-release to extended-release divalproex. Davis LL; Li X; Bartolucci AA; Williford RB; Lowe JS J Clin Psychiatry; 2007 Oct; 68(10):1546-51. PubMed ID: 17960970 [TBL] [Abstract][Full Text] [Related]
3. A case report that suggested that aspirin's effects on valproic acid metabolism may contribute to valproic acid's inducer effects on clozapine metabolism. Riesselman A; Strobl B; Cooley AT; de Leon J J Clin Psychopharmacol; 2013 Dec; 33(6):812-4. PubMed ID: 24113673 [No Abstract] [Full Text] [Related]
5. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241 [TBL] [Abstract][Full Text] [Related]
6. Ibuprofen May Increase Pharmacological Action of Valproate by Displacing It From Plasma Proteins: A Case Report. Lana F; MartÃ-Bonany J; de Leon J Am J Psychiatry; 2016 Sep; 173(9):941-2. PubMed ID: 27581700 [No Abstract] [Full Text] [Related]
7. Clozapine-induced stuttering, facial tics and myoclonic seizures: a case report. Begum M Aust N Z J Psychiatry; 2005 Mar; 39(3):202. PubMed ID: 15701074 [No Abstract] [Full Text] [Related]
8. Predicted serum valproic acid concentrations in patients missing and replacing a dose of extended-release divalproex sodium. Reed RC; Dutta S Am J Health Syst Pharm; 2004 Nov; 61(21):2284-9. PubMed ID: 15552636 [TBL] [Abstract][Full Text] [Related]
9. A multiphasic absorption model best characterizes gastrointestinal absorption of divalproex sodium extended-release tablets. Dutta S; Reed RC J Clin Pharmacol; 2006 Aug; 46(8):952-7. PubMed ID: 16855080 [No Abstract] [Full Text] [Related]
10. Every-12-hour administration of extended-release divalproex in patients with epilepsy: impact on plasma valproic acid concentrations. Reed RC; Dutta S; Cavanaugh JH; Locke C; Granneman GR Epilepsy Behav; 2006 Mar; 8(2):391-6. PubMed ID: 16473558 [TBL] [Abstract][Full Text] [Related]
11. Predicted plasma valproic acid concentrations in patients missing and replacing a full daily dose of extended-release divalproex sodium. Dutta S; Reed RC Am J Health Syst Pharm; 2006 May; 63(10):904-6. PubMed ID: 16675645 [No Abstract] [Full Text] [Related]
12. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder. Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385 [TBL] [Abstract][Full Text] [Related]